Sex: F
Vaccine: COVID19
Symptoms: Small fibre neuropathy, Systemic lupus erythematosus, Tinnitus, Vitreous floaters
Clinical narrative: Lupus / pre-lupus; two miscarriages; hyperthyroidism; Autoimmune disease/autoimmune markers ANA, which indicates auto-immune disease.; Tinnitus; Small fiber neuropathy; Eye floaters; Photophobia; numbness; tingling; This is a spontaneous report received from a Consumer or other non HCP and an Other HCP. Other Case identifier(s): MOD-2023-748863 (Moderna).  A 31-year-old female patient (pregnant) received BNT162b2 (BNT162B2), in Apr2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "she had a B12 deficiency" (unspecified if ongoing); "borderline Guillan Barre" (unspecified if ongoing), notes: she is borderline Guillan Barre and her doctor was concerned. The patient's concomitant medications were not reported. The following information was reported: HYPOAESTHESIA (non-serious) with onset Apr2021, 30 min after the suspect product(s) administration, outcome "unknown", described as "numbness"; PARAESTHESIA (non-serious) with onset Apr2021, 30 min after the suspect product(s) administration, outcome "unknown", described as "tingling"; SYSTEMIC LUPUS ERYTHEMATOSUS (medically significant), outcome "unknown", described as "Lupus / pre-lupus"; ABORTION SPONTANEOUS (medically significant), outcome "unknown", described as "two miscarriages"; HYPERTHYROIDISM (medically significant), outcome "unknown"; AUTOIMMUNE DISORDER (medically significant), outcome "unknown", described as "Autoimmune disease/autoimmune markers ANA, which indicates auto-immune disease."; TINNITUS (non-serious), outcome "unknown"; SMALL FIBRE NEUROPATHY (non-serious), outcome "unknown", described as "Small fiber neuropathy"; VITREOUS FLOATERS (non-serious), outcome "unknown", described as "Eye floaters"; PHOTOPHOBIA (non-serious), outcome "unknown". The pregnancy resulted in spontaneous abortion. The fetal outcome is intrauterine death. The patient underwent the following laboratory tests and procedures: Antibody test: (2021) Unknown results, notes: reporter was looking for an anti PEG antibody test, as patient was borderline Guillan Barre and her doctor was concerned; Biopsy: (2021) Unknown results, notes: patient had ongoing neurological issues and numbness and had multiple pathological and biopsy test; Blood test: (2021) all blood work came back fine; Histology: (2021) Unknown results, notes: patient had ongoing neurological issues and numbness and had multiple pathological and biopsy test. Clinical course: The patient got first shot. Six days later, had neurological problems - numbness and tingling. Now had pre-lupus, had two miscarriages, has tinnitus, small fiber neuropathy, eye floaters, and thyroid is damaged. And all because of your shot. The patient stated that had one Pfizer shot and had numbness and tingling. The patient stated got the shot first, and the patient got hers a week later. did not tell what happened. The patient repeats that had a Pfizer, and within 30 minutes, had numbness and tingling. doctor told not to get the second one. The patient stated Safety was already aware of it and had been contacted. stated that this was 2.5 years ago and they are still dealing with it. They will have nerve damage and autoimmune disease for the rest of their lives when they would have been fine with COVID. They were fit healthy people who were gaslit into taking the vaccines.The patient was diagnosed: pre-lupus, tinnitus, photophobia, small fiber neuropathy, hyperthyroidism, and autoimmune markers ANA, which indicates auto-immune disease.  The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021749083 Same reporter and product different patient/AE;